Showing results (161-170 of 454) with videos related to

Sort By:
Pageof 46
Journal of Drug Targeting|April 27, 2012
Fluorinated and pegylated polyaspartamide derivatives to increase solubility and efficacy of FlutamideAntonio Palumbo Piccionello, Giovanna Pitarresi, Andrea Pace, et al.
International Journal of Molecular Sciences|July 10, 2019
Strategies against Nonsense: Oxadiazoles as Translational Readthrough-Inducing Drugs (TRIDs)Ambra Campofelice, Laura Lentini, Aldo Di Leonardo, et al.
Musculoskeletal Surgery|March 6, 2025
Mortality risk factor in centenarians with proximal femoral fracturesRoberto Casadei, Marcello Lughi, Claudio Perini, et al.
Frontiers in Oncology|December 9, 2022
Paget's disease of the breast: Our 20 years' experienceLorenzo Scardina, Alba Di Leone, Stefano Magno, et al.
Anticancer Research|July 28, 2004
Epirubicin plus docetaxel in metastatic breast cancer: escalating dose does not improve efficacy. A phase II studyAlessandra Fabi, Paola Papaldo, Maria Simona Pino, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 6, 2003
Is delayed chemotherapy-induced emesis well managed in oncological clinical practice? An observational studyAlessandra Fabi, Mario Barduagni, Salvatore Lauro, et al.
The Breast Journal|November 6, 2009
Time to first tumor progression as outcome predictor of a second trasuzumab-based therapy beyond progression in HER-2 positive metastatic breast cancerGiulio Metro, Diana Giannarelli, Donatello Gemma, et al.
Cancers|May 14, 2022
PI3K Inhibitors in Advanced Breast Cancer: The Past, The Present, New Challenges and Future PerspectivesPaola Fuso, Margherita Muratore, Tatiana D'Angelo, et al.
Future Oncology (London, England)|June 6, 2020
Nanoparticle albumin-bound paclitaxel/liposomal-encapsulated doxorubicin in HER2-negative metastatic breast cancer patientsAlessandra Fabi, Gianluigi Ferretti, Paola Malaguti, et al.
Cell Reports|September 14, 2024
Transient splicing inhibition causes persistent DNA damage and chemotherapy vulnerability in triple-negative breast cancerCinzia Caggiano, Valerio Petrera, Miriana Ferri, et al.
Pageof 46